The US pharmaceutical group has signed a joint venture with the Asian generic drugs manufacturer to launch new formulations and combinations of off-patent medicines Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,